-
Sign In
- Sony Biotechnology
- Sony Biotechnology
CD16 is known as low affinity IgG receptor III (FcγRIII). It is expressed as two distinct forms (CD16a and CD16b). CD16a (FcγRIIIA) is a 50-65 kD polypeptide-anchored transmembrane protein. It is expressed on the surface of NK cells, activated monocytes, macrophages, and placental trophoblasts in humans. CD16b (FcγRIIIB) is a 48 kD glycosylphosphatidylinositol (GPI)-anchored protein. Its extracellular domain is over 95% homologous to that of CD16a, and it is expressed specifically on neutrophils. CD16 binds aggregated IgG or IgG-antigen complex which functions in NK cell activation, phagocytosis, and antibody-dependent cell-mediated cytotoxicity (ADCC).
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤2.0 microg per million cells in 100 microL volume. It is recommended that the reagent be titrated for optimal performance for each application.
1. Knapp W, et al. Eds. 1989. Leucocyte Typing IV. Oxford University Press. New York.
2. Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
3. Edberg J, et al. 1997. J. Immunol. 159:3849. (IP)
4. Hoshino S, et al. 1991. Blood 78:3232. (Stim)
5. Tamm A, et al. 1996. Immunol. 157:1576. (Block)
6. Da Silva DM, et al. 2001. Int. Immunol. 13:633. (IHC)
7. Holl V, et al. 2004. J. Immunol. 173:6274. (Block)
8. Hober D, et al. 2002. J. Gen. Virol. 83:2169. (Block)
9. Brainard DM, et al. 2009. J. Virol. 83:7305. PubMed
10. Smed-Sörensen A, et al. 2008. Blood 111:5037. (Block) PubMed
11. Timmerman KL, et al. 2008. J. Leukoc. Biol. 84:1271. (FC) PubMed
12. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
13. Rout N, et al. 2010. PLoS One 5:e9787. (FC)
14. Kim WK, et al. 2006. Am. J. Pathol. 168:822. (FC)
15. Boltz A, et al. 2011. J. Biol Chem. 286:21896. PubMed
16. Wu Z, et al. 2013. J. Virol. 87:7717. PubMed